Skip to Main Content

Paper Details

Sequential azacitidine and lenalidomide for patients with relapsed and refractory acute myeloid leukemia: Clinical results and predictive modeling using computational analysis.
Leuk Res
4
2019
AML, Patients, R/R AML, acute myeloid leukemia, azacitidine, lenalidomide, myelodysplastic syndrome, patient, patients
Author NameAffiliation
Brett M StevensUniversity of Colorado Division of Hematology
Amanda WintersUniversity of Colorado Children's Hospital
Taher Abbasi
Shireen Vali
Leylah M DrusboskyUniversity of Florida
Christopher R CogleUniversity of Florida
Diana AbbottCenter for Innovative Design and Analysis, University of Colorado
Veronica Clavijo JordanUniversity of Colorado Division of Hematology
Veronica Clavijo JordanUniversity of Colorado Division of Hematology
Clayton A SmithUniversity of Colorado Division of Hematology
Daniel A PollyeaUniversity of Colorado Division of Hematology
  • 1 - 11

Datasets

Release 1.2